nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—saliva—hepatitis B	0.0319	0.307	CbGeAlD
Aminosalicylic Acid—MPO—blood plasma—hepatitis B	0.0139	0.134	CbGeAlD
Aminosalicylic Acid—CHUK—blood—hepatitis B	0.0107	0.103	CbGeAlD
Aminosalicylic Acid—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.00915	0.0226	CcSEcCtD
Aminosalicylic Acid—Jaundice—Adefovir Dipivoxil—hepatitis B	0.00879	0.0217	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Telbivudine—hepatitis B	0.00857	0.0212	CcSEcCtD
Aminosalicylic Acid—CHUK—liver—hepatitis B	0.00836	0.0802	CbGeAlD
Aminosalicylic Acid—Hepatitis—Entecavir—hepatitis B	0.0083	0.0205	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Adefovir Dipivoxil—hepatitis B	0.0081	0.02	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.00799	0.0198	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.00794	0.0196	CcSEcCtD
Aminosalicylic Acid—Vasculitis—Lamivudine—hepatitis B	0.00784	0.0194	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Telbivudine—hepatitis B	0.00744	0.0184	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Entecavir—hepatitis B	0.00722	0.0179	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Adefovir Dipivoxil—hepatitis B	0.00705	0.0174	CcSEcCtD
Aminosalicylic Acid—Flatulence—Adefovir Dipivoxil—hepatitis B	0.00694	0.0172	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Telbivudine—hepatitis B	0.00682	0.0169	CcSEcCtD
Aminosalicylic Acid—PTGS1—blood plasma—hepatitis B	0.0066	0.0633	CbGeAlD
Aminosalicylic Acid—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00651	0.0161	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Entecavir—hepatitis B	0.00647	0.016	CcSEcCtD
Aminosalicylic Acid—PTGS2—blood plasma—hepatitis B	0.0063	0.0605	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Entecavir—hepatitis B	0.00611	0.0151	CcSEcCtD
Aminosalicylic Acid—ALOX5—blood—hepatitis B	0.00602	0.0578	CbGeAlD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Adefovir Dipivoxil—hepatitis B	0.00596	0.0147	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Telbivudine—hepatitis B	0.00593	0.0147	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Telbivudine—hepatitis B	0.00581	0.0144	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Entecavir—hepatitis B	0.00578	0.0143	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Entecavir—hepatitis B	0.00573	0.0142	CcSEcCtD
Aminosalicylic Acid—Hypoglycaemia—Lamivudine—hepatitis B	0.00569	0.0141	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Adefovir Dipivoxil—hepatitis B	0.00564	0.0139	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Adefovir Dipivoxil—hepatitis B	0.00563	0.0139	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Adefovir Dipivoxil—hepatitis B	0.00559	0.0138	CcSEcCtD
Aminosalicylic Acid—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00548	0.0136	CcSEcCtD
Aminosalicylic Acid—MPO—blood—hepatitis B	0.00509	0.0489	CbGeAlD
Aminosalicylic Acid—Gastrointestinal disorder—Entecavir—hepatitis B	0.00509	0.0126	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Telbivudine—hepatitis B	0.00502	0.0124	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.005	0.0124	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00497	0.0123	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Lamivudine—hepatitis B	0.00483	0.0119	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Entecavir—hepatitis B	0.00482	0.0119	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Telbivudine—hepatitis B	0.00475	0.0117	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Telbivudine—hepatitis B	0.00474	0.0117	CcSEcCtD
Aminosalicylic Acid—ALOX5—liver—hepatitis B	0.00471	0.0452	CbGeAlD
Aminosalicylic Acid—Skin disorder—Telbivudine—hepatitis B	0.0047	0.0116	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.0047	0.0116	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Entecavir—hepatitis B	0.00466	0.0115	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Entecavir—hepatitis B	0.00466	0.0115	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00455	0.0112	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00455	0.0112	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Lamivudine—hepatitis B	0.00419	0.0104	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00418	0.0103	CcSEcCtD
Aminosalicylic Acid—Jaundice—Lamivudine—hepatitis B	0.00417	0.0103	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Entecavir—hepatitis B	0.00403	0.00997	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Lamivudine—hepatitis B	0.00399	0.00988	CcSEcCtD
Aminosalicylic Acid—MPO—liver—hepatitis B	0.00398	0.0383	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Telbivudine—hepatitis B	0.00396	0.00979	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00394	0.00973	CcSEcCtD
Aminosalicylic Acid—Dizziness—Entecavir—hepatitis B	0.0039	0.00964	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Lamivudine—hepatitis B	0.00384	0.0095	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Telbivudine—hepatitis B	0.00383	0.00947	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Telbivudine—hepatitis B	0.00383	0.00947	CcSEcCtD
Aminosalicylic Acid—Vomiting—Entecavir—hepatitis B	0.00375	0.00927	CcSEcCtD
Aminosalicylic Acid—Rash—Entecavir—hepatitis B	0.00372	0.00919	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Entecavir—hepatitis B	0.00371	0.00918	CcSEcCtD
Aminosalicylic Acid—Headache—Entecavir—hepatitis B	0.00369	0.00913	CcSEcCtD
Aminosalicylic Acid—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00366	0.00904	CcSEcCtD
Aminosalicylic Acid—Rash—Adefovir Dipivoxil—hepatitis B	0.00363	0.00897	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00362	0.00896	CcSEcCtD
Aminosalicylic Acid—Headache—Adefovir Dipivoxil—hepatitis B	0.0036	0.00891	CcSEcCtD
Aminosalicylic Acid—Nausea—Entecavir—hepatitis B	0.0035	0.00866	CcSEcCtD
Aminosalicylic Acid—Nausea—Adefovir Dipivoxil—hepatitis B	0.00342	0.00845	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Lamivudine—hepatitis B	0.00334	0.00827	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Telbivudine—hepatitis B	0.00331	0.00819	CcSEcCtD
Aminosalicylic Acid—Flatulence—Lamivudine—hepatitis B	0.00329	0.00815	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Lamivudine—hepatitis B	0.00327	0.0081	CcSEcCtD
Aminosalicylic Acid—Dizziness—Telbivudine—hepatitis B	0.0032	0.00792	CcSEcCtD
Aminosalicylic Acid—Anaemia—Lamivudine—hepatitis B	0.00309	0.00764	CcSEcCtD
Aminosalicylic Acid—Vomiting—Telbivudine—hepatitis B	0.00308	0.00761	CcSEcCtD
Aminosalicylic Acid—Rash—Telbivudine—hepatitis B	0.00305	0.00755	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Telbivudine—hepatitis B	0.00305	0.00754	CcSEcCtD
Aminosalicylic Acid—Headache—Telbivudine—hepatitis B	0.00303	0.0075	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Lamivudine—hepatitis B	0.00299	0.0074	CcSEcCtD
Aminosalicylic Acid—Nausea—Telbivudine—hepatitis B	0.00288	0.00711	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—hepatitis B	0.00283	0.00699	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Lamivudine—hepatitis B	0.00268	0.00662	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Lamivudine—hepatitis B	0.00267	0.00661	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Lamivudine—hepatitis B	0.00265	0.00656	CcSEcCtD
Aminosalicylic Acid—Anorexia—Lamivudine—hepatitis B	0.0026	0.00643	CcSEcCtD
Aminosalicylic Acid—PTGS1—blood—hepatitis B	0.00242	0.0232	CbGeAlD
Aminosalicylic Acid—Decreased appetite—Lamivudine—hepatitis B	0.00237	0.00587	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00236	0.00583	CcSEcCtD
Aminosalicylic Acid—PTGS2—blood—hepatitis B	0.00231	0.0222	CbGeAlD
Aminosalicylic Acid—Gastrointestinal pain—Lamivudine—hepatitis B	0.00223	0.00552	CcSEcCtD
Aminosalicylic Acid—Urticaria—Lamivudine—hepatitis B	0.00217	0.00536	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Lamivudine—hepatitis B	0.00216	0.00534	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Lamivudine—hepatitis B	0.00216	0.00534	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Lamivudine—hepatitis B	0.00201	0.00497	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Lamivudine—hepatitis B	0.00187	0.00462	CcSEcCtD
Aminosalicylic Acid—PTGS2—liver—hepatitis B	0.00181	0.0173	CbGeAlD
Aminosalicylic Acid—Dizziness—Lamivudine—hepatitis B	0.0018	0.00446	CcSEcCtD
Aminosalicylic Acid—Vomiting—Lamivudine—hepatitis B	0.00174	0.00429	CcSEcCtD
Aminosalicylic Acid—Rash—Lamivudine—hepatitis B	0.00172	0.00426	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Lamivudine—hepatitis B	0.00172	0.00425	CcSEcCtD
Aminosalicylic Acid—Headache—Lamivudine—hepatitis B	0.00171	0.00423	CcSEcCtD
Aminosalicylic Acid—Nausea—Lamivudine—hepatitis B	0.00162	0.00401	CcSEcCtD
Aminosalicylic Acid—Diflunisal—ALB—hepatitis B	0.00139	0.643	CrCbGaD
Aminosalicylic Acid—Salicylic acid—ALB—hepatitis B	0.000774	0.358	CrCbGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—NFKB1—hepatitis B	0.000503	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—TGFB1—hepatitis B	0.000503	0.00103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL18—hepatitis B	0.000499	0.00102	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—hepatitis B	0.000496	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—hepatitis B	0.000496	0.00101	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DPA1—hepatitis B	0.00048	0.000981	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—ALB—hepatitis B	0.000479	0.000979	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—hepatitis B	0.000476	0.000972	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TLR4—hepatitis B	0.000474	0.000969	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—hepatitis B	0.000473	0.000967	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN2A—hepatitis B	0.000465	0.000951	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—hepatitis B	0.000461	0.000942	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000458	0.000937	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—UBE2L3—hepatitis B	0.000455	0.00093	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD274—hepatitis B	0.000455	0.00093	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—NOS2—hepatitis B	0.000451	0.000921	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000446	0.000912	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—hepatitis B	0.000445	0.000909	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—SAG—hepatitis B	0.000443	0.000905	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOBEC3G—hepatitis B	0.000443	0.000905	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CD4—hepatitis B	0.000438	0.000896	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-A—hepatitis B	0.000438	0.000896	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—hepatitis B	0.000438	0.000895	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IFNG—hepatitis B	0.000437	0.000894	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—hepatitis B	0.000437	0.000893	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—CTNNB1—hepatitis B	0.000427	0.000873	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—NFKB1—hepatitis B	0.000426	0.000871	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—hepatitis B	0.000425	0.000868	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—CDKN1A—hepatitis B	0.000424	0.000867	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—PTEN—hepatitis B	0.000423	0.000865	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—NFKB1—hepatitis B	0.000421	0.000861	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PDCD1—hepatitis B	0.000416	0.00085	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—NFKB1—hepatitis B	0.000414	0.000847	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000411	0.00084	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—CDKN1A—hepatitis B	0.000406	0.00083	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—PTEN—hepatitis B	0.000405	0.000828	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000401	0.000819	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—hepatitis B	0.0004	0.000818	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—CDKN1A—hepatitis B	0.0004	0.000816	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000399	0.000815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—PTEN—hepatitis B	0.000399	0.000815	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—IL6—hepatitis B	0.000396	0.00081	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—hepatitis B	0.000393	0.000803	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNGR1—hepatitis B	0.000387	0.00079	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—hepatitis B	0.000386	0.000788	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HSPA5—hepatitis B	0.000385	0.000786	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—CDKN1A—hepatitis B	0.000382	0.00078	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—PTEN—hepatitis B	0.000381	0.000778	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CDKN1A—hepatitis B	0.00038	0.000777	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—CDKN1A—hepatitis B	0.00038	0.000776	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—PTEN—hepatitis B	0.000379	0.000774	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—hepatitis B	0.000379	0.000774	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—CDKN1A—hepatitis B	0.000378	0.000772	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—PTEN—hepatitis B	0.000377	0.00077	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—CDKN1A—hepatitis B	0.000376	0.000768	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—PTEN—hepatitis B	0.000375	0.000767	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—hepatitis B	0.000372	0.00076	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—hepatitis B	0.000372	0.00076	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000372	0.00076	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—hepatitis B	0.000371	0.000757	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PTEN—hepatitis B	0.00037	0.000756	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—hepatitis B	0.000368	0.000752	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—hepatitis B	0.000366	0.000747	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR2—hepatitis B	0.000364	0.000744	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—NFKB1—hepatitis B	0.000364	0.000744	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DPB1—hepatitis B	0.000363	0.000742	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNB1—hepatitis B	0.000361	0.000738	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000359	0.000733	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—hepatitis B	0.000357	0.000729	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—ALB—hepatitis B	0.000355	0.000726	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—CDKN1A—hepatitis B	0.000354	0.000723	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—CDKN1A—hepatitis B	0.000354	0.000723	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—CDKN1A—hepatitis B	0.000354	0.000723	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—PTEN—hepatitis B	0.000353	0.000721	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—PTEN—hepatitis B	0.000353	0.000721	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—PTEN—hepatitis B	0.000353	0.000721	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNA1—hepatitis B	0.000352	0.00072	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NFKB1—hepatitis B	0.000351	0.000718	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—hepatitis B	0.000351	0.000717	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—CDKN1A—hepatitis B	0.000351	0.000716	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—PTEN—hepatitis B	0.00035	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—CDKN1A—hepatitis B	0.000347	0.00071	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—PTEN—hepatitis B	0.000347	0.000708	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—CDKN1A—hepatitis B	0.000346	0.000707	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IFNG—hepatitis B	0.000346	0.000707	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—PTEN—hepatitis B	0.000345	0.000705	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—hepatitis B	0.000343	0.0007	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000341	0.000696	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CYP2A6—hepatitis B	0.000335	0.000685	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000333	0.00068	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—MX1—hepatitis B	0.000333	0.00068	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000332	0.000679	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—hepatitis B	0.000331	0.000677	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.00033	0.000675	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD14—hepatitis B	0.000328	0.00067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFNA2—hepatitis B	0.000328	0.00067	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—CDKN1A—hepatitis B	0.000327	0.000669	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—hepatitis B	0.000327	0.000669	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—PTEN—hepatitis B	0.000327	0.000667	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NFKB1—hepatitis B	0.000325	0.000664	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—hepatitis B	0.000316	0.000645	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—CDKN1A—hepatitis B	0.000313	0.00064	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000313	0.000639	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—PTEN—hepatitis B	0.000313	0.000639	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—RIT2—hepatitis B	0.00031	0.000634	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SAG—hepatitis B	0.00031	0.000634	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL2—hepatitis B	0.000307	0.000628	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GOT2—hepatitis B	0.000303	0.00062	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—hepatitis B	0.000297	0.000607	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNG—hepatitis B	0.000292	0.000598	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—hepatitis B	0.000288	0.000588	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—hepatitis B	0.000283	0.000578	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000275	0.000563	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000274	0.000559	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—PTEN—hepatitis B	0.000271	0.000554	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD40LG—hepatitis B	0.000268	0.000547	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—hepatitis B	0.000267	0.000547	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—hepatitis B	0.000265	0.000541	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—hepatitis B	0.000264	0.00054	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—hepatitis B	0.000264	0.00054	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—SAG—hepatitis B	0.000262	0.000536	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOBEC3G—hepatitis B	0.000262	0.000536	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GOT1—hepatitis B	0.000262	0.000535	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—GGT1—hepatitis B	0.000262	0.000535	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL2—hepatitis B	0.00026	0.000531	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000257	0.000525	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000255	0.000521	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—hepatitis B	0.000253	0.000517	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—AKR1B1—hepatitis B	0.00025	0.000512	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—hepatitis B	0.000249	0.000509	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NFKB1—hepatitis B	0.000243	0.000497	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—CDKN1A—hepatitis B	0.000241	0.000492	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—PTEN—hepatitis B	0.00024	0.000491	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GGT2—hepatitis B	0.00024	0.000491	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TGFB1—hepatitis B	0.00024	0.00049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NFKB1—hepatitis B	0.000239	0.000489	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000239	0.000488	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—hepatitis B	0.000238	0.000486	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—hepatitis B	0.000237	0.000484	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-A—hepatitis B	0.000236	0.000482	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—hepatitis B	0.000235	0.000481	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—hepatitis B	0.000234	0.000479	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HSPA5—hepatitis B	0.000233	0.000477	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—hepatitis B	0.000228	0.000467	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000227	0.000463	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TLR4—hepatitis B	0.000225	0.000459	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—hepatitis B	0.000224	0.000457	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—hepatitis B	0.00022	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—hepatitis B	0.00022	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—hepatitis B	0.00022	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DPB1—hepatitis B	0.00022	0.00045	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—hepatitis B	0.000218	0.000446	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—hepatitis B	0.000217	0.000443	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—hepatitis B	0.000216	0.000441	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—hepatitis B	0.000216	0.000441	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR2—hepatitis B	0.000212	0.000433	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GOT2—hepatitis B	0.00021	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNB1—hepatitis B	0.00021	0.00043	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA1—hepatitis B	0.000205	0.000419	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	0.000202	0.000414	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000202	0.000412	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—AKR1B1—hepatitis B	0.000199	0.000406	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—hepatitis B	0.000197	0.000403	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000197	0.000403	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000197	0.000402	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000196	0.0004	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—hepatitis B	0.000195	0.000399	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNA2—hepatitis B	0.000191	0.00039	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD14—hepatitis B	0.000191	0.00039	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GGT2—hepatitis B	0.000191	0.000389	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—GOT1—hepatitis B	0.000182	0.000371	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—hepatitis B	0.000181	0.000369	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000163	0.000333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL18—hepatitis B	0.000163	0.000333	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD40LG—hepatitis B	0.000162	0.000332	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—hepatitis B	0.000161	0.000328	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—hepatitis B	0.000158	0.000324	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—hepatitis B	0.000153	0.000312	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	0.000152	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—hepatitis B	0.000152	0.000311	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—hepatitis B	0.00015	0.000307	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2A6—hepatitis B	0.000145	0.000297	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—hepatitis B	0.000143	0.000293	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CTNNB1—hepatitis B	0.000141	0.000287	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—ALB—hepatitis B	0.000139	0.000285	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CDKN1A—hepatitis B	0.000137	0.000281	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—PTEN—hepatitis B	0.000137	0.00028	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKB1—hepatitis B	0.000136	0.000279	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CCR5—hepatitis B	0.000136	0.000277	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000136	0.000277	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	0.000134	0.000274	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—hepatitis B	0.000132	0.00027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CDKN1A—hepatitis B	0.000132	0.00027	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—PTEN—hepatitis B	0.000132	0.000269	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GOT2—hepatitis B	0.000132	0.000269	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKB1—hepatitis B	0.000131	0.000268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TLR4—hepatitis B	0.000131	0.000268	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—hepatitis B	0.000131	0.000267	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GOT2—hepatitis B	0.000125	0.000255	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL10—hepatitis B	0.000122	0.00025	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2A6—hepatitis B	0.000115	0.000236	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—hepatitis B	0.000115	0.000235	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GGT1—hepatitis B	0.000114	0.000232	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—GOT1—hepatitis B	0.000114	0.000232	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—ALB—hepatitis B	0.000108	0.00022	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—GOT1—hepatitis B	0.000108	0.00022	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PTEN—hepatitis B	0.000106	0.000217	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GOT2—hepatitis B	0.000104	0.000213	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	0.000103	0.000211	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—hepatitis B	9.55e-05	0.000195	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCR5—hepatitis B	9.5e-05	0.000194	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—hepatitis B	9.23e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GOT1—hepatitis B	9.01e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—GGT1—hepatitis B	9.01e-05	0.000184	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—hepatitis B	8.57e-05	0.000175	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—hepatitis B	8.52e-05	0.000174	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL2—hepatitis B	8.49e-05	0.000173	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	8.21e-05	0.000168	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CTNNB1—hepatitis B	8.19e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—F2—hepatitis B	8.15e-05	0.000167	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CCR5—hepatitis B	8.03e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CDKN1A—hepatitis B	8e-05	0.000164	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—PTEN—hepatitis B	7.99e-05	0.000163	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKB1—hepatitis B	7.95e-05	0.000162	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—hepatitis B	7.83e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CTNNB1—hepatitis B	7.57e-05	0.000155	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CDKN1A—hepatitis B	7.39e-05	0.000151	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—PTEN—hepatitis B	7.37e-05	0.000151	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—hepatitis B	6.81e-05	0.000139	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TGFB1—hepatitis B	6.11e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—ALB—hepatitis B	6.04e-05	0.000123	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL2—hepatitis B	5.49e-05	0.000112	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CTNNB1—hepatitis B	5.3e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CDKN1A—hepatitis B	5.18e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—PTEN—hepatitis B	5.16e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKB1—hepatitis B	5.14e-05	0.000105	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—hepatitis B	5.05e-05	0.000103	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—hepatitis B	4.99e-05	0.000102	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—ALB—hepatitis B	4.79e-05	9.8e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PTEN—hepatitis B	4.61e-05	9.42e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—hepatitis B	4.61e-05	9.41e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CTNNB1—hepatitis B	4.48e-05	9.16e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CDKN1A—hepatitis B	4.38e-05	8.95e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—PTEN—hepatitis B	4.37e-05	8.93e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TGFB1—hepatitis B	4.28e-05	8.75e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PTEN—hepatitis B	3.66e-05	7.48e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TGFB1—hepatitis B	3.62e-05	7.4e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—hepatitis B	3.52e-05	7.2e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—hepatitis B	3.23e-05	6.59e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—hepatitis B	2.73e-05	5.58e-05	CbGpPWpGaD
